| What is expected of a medical director in the Centers for Medicare and Medicaid Services Conditions of Coverage? | |
| | |
MedLine Citation:
|
PMID: 21228568 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
The Medicare Conditions for Coverage for dialysis facilities, effective since 2008, make the medical director responsible for all levels of quality patient care in the facility. This includes issues such as water quality, infection control, staff education, policy/procedure development and implementation, dialyzer reuse, involuntary discharges, and patient safety. Most importantly, the medical director is the leader of the team responsible for quality assessment and performance improvement, which is central to the process of continuous quality improvement in the dialysis facility and the basis for much of Medicare's evaluation of facility performance. Through the measures assessment tool, the Conditions for Coverage specify the required domains for quality improvement activities in the dialysis facility, including dialysis adequacy, nutrition, bone disease, anemia management, vascular access, medical errors, patient satisfaction, and infection control. Under the leadership of the medical director, the quality assessment and performance improvement team identifies opportunities for improvement, tests and implements interventions, collects data, interprets results, and links system change with improved outcomes. These activities are rigorously documented and provide evidence to Medicare that the facility is acting responsibly to provide the best possible services for which it is being paid. The medical director is fairly compensated for his/her services by the facility, but must always act in the patients' best interest when evaluating policy changes directed at cost containment. The success of a medical director in shepherding positive change in a dialysis facility can be immensely satisfying as it impacts on patients other than his/her own. |
| | |
Authors:
|
Jay B Wish |
Related Documents
:
|
9553598 - When to worry about spider bites. inaccurate diagnosis can have serious, even fatal, co... 15225568 - Preclinical testing of three south american antivenoms against the venoms of five medic... 1299068 - Ecological border of distribution of trichinella nativa britov et boev, 1972 and t. nel... 16959478 - Thielavia gigaspora, a new thermotolerant ascomycete from egypt. 20097638 - Patient-centered care in the community-based compounding practice setting. 9374018 - Responsibility for crime and injury when drunk. |
Publication Detail:
|
Type: Journal Article Date: 2011-01-10 |
Journal Detail:
|
Title: Blood purification Volume: 31 ISSN: 1421-9735 ISO Abbreviation: Blood Purif. Publication Date: 2011 |
Date Detail:
|
Created Date: 2011-01-13 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8402040 Medline TA: Blood Purif Country: Switzerland |
Other Details:
|
Languages: eng Pagination: 61-5 Citation Subset: IM |
Copyright Information:
|
Copyright © 2011 S. Karger AG, Basel. |
Affiliation:
|
University Hospitals Case Medical Center, 11100 Euclid Avenue, Cleveland, OH 44106, USA. jaywish@earthlink.net |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Functional Results of Vibrant Soundbridge Middle Ear Implants in Conductive and Mixed Hearing Losses...
Next Document: Potential effects of the new Medicare Prospective Payment System on drug prescription in end-stage r...